{
  "id": 6991577,
  "title": "Shedding new light on DNA repair in early human embryos, with implications for gene editing",
  "url": "https://urgent.news/2026/09/12/shedding-new-light-on-dna-repair-in-early-human-embryos-with",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-12T21:00:05.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-dna-early-human-embryos-implications.html"
  },
  "original_language": "en",
  "account": "New research published in Nature addresses fundamental questions about how early human embryos repair DNA damage caused by gene editing, a crucial area for developing targeted treatments to prevent inherited diseases. First author Štěpán Jeřábek, from Columbia University and IOCB Prague, led the study which involved IOCB Prague scientists Iva Pichová and Michal Doležal.\n\nThe research reveals that early human embryos can effectively repair single-strand DNA damage, but the repair of double-strand breaks is significantly less reliable at this stage. To investigate these repair mechanisms, researchers induced targeted changes into two well-known genes using CRISPR–Cas9 and base editing. The results showed that base editing produced only a single-strand nick, while CRISPR–Cas9 introduced double-strand breaks.\n\nBy using protein-based editors instead of mRNA, the study found these edits were compatible with normal embryonic development. Importantly, stem cells derived from edited six-day-old embryos provided sufficient genetic material for in-depth analyses, allowing researchers to study the effects of gene editing in subsequent generations of cells.\n\nThe study highlights both the potential and the limitations of current genome-editing technologies. While base editing offers improved precision over CRISPR–Cas9, many safety questions must still be answered before this method can be considered for clinical use in human embryos. Jeřábek emphasized that the study's goal was not to develop a method for genetically modifying human embryos, but rather to better understand DNA repair mechanisms during early human development. The research was conducted under ethical oversight at Columbia University and attracted international media attention shortly after publication.",
  "summary": "Treating inherited diseases is one of the greatest challenges in modern medicine. In the future, targeted gene corrections at the earliest stages of embryonic development could help prevent certain inherited diseases from developing and being passed on to future generations. However, the safety of such approaches depends on how human embryos repair the DNA damage caused during gene editing and on…",
  "key_points": [
    "Early human embryos can repair single-strand DNA damage effectively.",
    "Double-strand break repair in early embryos is significantly less reliable.",
    "Study uses CRISPR–Cas9 and base editing to understand DNA repair mechanisms."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}